Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Total Assets Over TimeStrong
Percentile Rank100
3Y CAGR+11.2%
5Y CAGR+3.5%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+11.2%/yr
vs +8.4%/yr prior
5Y CAGR
+3.5%/yr
Recent acceleration
Acceleration
+2.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$913.17M+0.3%
2024$910.43M+16.7%
2023$780.35M+17.5%
2022$663.98M-14.6%
2021$777.33M+1.2%
2020$768.46M+123.0%
2019$344.65M-28.3%
2018$480.82M+209.5%
2017$155.37M-9.6%
2016$171.89M-